[Application of the lymphoblastic transformation test (LTT) to the diagnosis of drug-induced hepatitis].
D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis*; D004342:Drug Hypersensitivity; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D010630:Phenindione / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects
D000995:Antitubercular Agents; D010640:Phenothiazines; D010630:Phenindione; D007213:Indomethacin
Application du test de transformation lymphoblastique (TTL) au diagnostic de certaines hépatites médicamenteuses.